Skip to main content
High RiskFDAfda-F-2283-2016E COLI

Tortilla Encrusted Breader for Tilapia, Net Wt. 40 lbs, Sm# 1000323591, MFG For High Liner Foods, Newport News, VA 23603.

Units Affected
87
Recall Date
July 7, 2016
Issuing Agency
Hazard
E Coli

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2283-2016.

Product was manufactured with flour recalled by General Mills due to Ecoli contaminated.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2283-2016.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Southeastern Mills Custom Seasoning Solutions or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2283-2016.

Southeastern Mills Custom Seasoning Solutions

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Southeastern Mills Custom Seasoning Solutions Recall FAQ

Southeastern Mills Custom Seasoning Solutions is the subject of a bakery & grains safety report: Tortilla Encrusted Breader for Tilapia, Net Wt. 40 lbs, Sm# 1000323591, MFG For High Liner Foods, Newport News, VA 23603.. The notice was published on July 7, 2016 by the U.S. Food and Drug Administration (FDA). Approximately 87 units are potentially affected.